Form 8-K - Current report:
SEC Accession No. 0001493152-24-039529
Filing Date
2024-10-04
Accepted
2024-10-04 16:30:20
Documents
15
Period of Report
2024-10-03
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46752
2 ex99-1.htm EX-99.1 7173
  Complete submission text file 0001493152-24-039529.txt   286968

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vhaq-20241003.xsd EX-101.SCH 3709
4 XBRL DEFINITION FILE vhaq-20241003_def.xml EX-101.DEF 30648
5 XBRL LABEL FILE vhaq-20241003_lab.xml EX-101.LAB 37383
6 XBRL PRESENTATION FILE vhaq-20241003_pre.xml EX-101.PRE 27663
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6754
Mailing Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326
Business Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39827 | Film No.: 241355255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)